Customer Guest
please type the captcha code.
Register|Generate Password|Dos and Don'ts of Demat Account
For Login related queries e-mail: emkayassist@emkayglobal.com
"Attention Investors
1. Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. 2. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from depository on your email id and/or mobile number to create pledge. 3. Pay 20% upfront margin of the transaction value to trade in cash market segment. 4. Investors may please refer to the Exchange's Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020 and NSE/INSP/45534 dated August 31, 2020 and other guidelines issued from time to time in this regard. 5. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month. 6.Investor Charter 7.Disclosure of Complaints 8.COMPLAINTS / SCORES 9. Verify Nomination in Account, click on link (:: Central Depository Services (India) Limited :: )
.......... Issued in the interest of Investors"
Regenerate OTP
Please contact to emkayassist@emkayglobal.com
Please select Mobile No and Email Id for OTP
Login | Register
Login | Register|Forgot password?
Appointment of M/s Panchal S K and Associates as the Statutory Auditor of the Company.more...
The Board Meeting to be held on 07/02/2026 Stands Cancelled.more...
Resignation of statutory auditormore...
Resignation of Statutory Auditormore...
Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 inter alia t...more...
Commencement of Commercial Production at Unit-II of Asston Pharmaceuticals Limited.more...
Compliance certificate under Regulation 74(5) of SEBI (DP) Regulation 2018more...
Meeting updatemore...
Outcome of the Board Meeting scheduled to be held on 05th January 2026more...
Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/01/2026 inter alia to conside...more...
Intimation of the additional capacity installation at the new manufacturing unit (Unit-II) of Asston Pharmaceuticals Limited.more...
Unaudited Financial Results for Half Year Ended 30th September 2025 along with a limited review reportmore...
Intimation of the Outcome of Board Meeting Scheduled to be held on 14th November 2025.more...
Asston Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 inter alia to conside...more...
As of September 2025 50.66% is owned by Indian Promoters and 49.34% by Public. Top three Promoters holding highest number of shares of Assto...more...
Submission of compliance certificate pursuant to Regulation 74(5) of SEBI (Depositories and Participants) regulation 2018more...
Appointment of Mr. Yogesh Supekar DIN: 11344916 as Non Executive Non Independent Director.more...
Meeting updates of Board Meeting scheduled to be heled on 16th October 2025more...
Appointment of Mr. Rishi Upadhaya as Company Secretary and compliance Officer of the Companymore...
BOARD MEETINGS Company Name : Beryl Drugs Date : 01-04-2026